We are live on ! Find out more
VRXA icon

Veraxa Biotech

8 hedge funds and large institutions have $1.66M invested in Veraxa Biotech in 2026 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

652% more capital inflows, than outflows

Capital inflows: $2.09M | Capital outflows: $278K

0.6% more ownership

Funds ownership: 0.34% → 0.94% (+0.6%)

0% more funds holding

Funds holding: 8 → 8 (0)

0% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 4

50% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 2

Holders
8
Holders Change
–
Holders Change %
0%
% of All Funds
0.1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
1
Reduced
2
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

VRXA Hedge Fund Activity: Q3 2026 in Review

8 of the 8,172 institutional investors tracked by Wall St. Rank reported a position in Veraxa Biotech (VRXA) for Q3 2026, worth a combined $1.66M — up 177% from $600K a quarter earlier.

Fund positioning in VRXA was balanced in Q3 2026: 4 funds opened new positions, 4 closed out, 1 added to existing stakes and 2 trimmed.

The largest buyer was Yorkville Advisors Global, opening a new position worth an estimated $1.87M. The largest seller was UBS Group, cutting an estimated $153K.

  • 8 institutional investors held Veraxa Biotech (VRXA) as of Q3 2026, unchanged from Q2 2026.
  • Funds reported $1.66M of Veraxa Biotech stock for Q3 2026, up 177% quarter-over-quarter.
  • 4 funds opened new Veraxa Biotech positions in Q3 2026 and 4 closed out, a net change of 0 holders.
  • The largest Veraxa Biotech buyer in Q3 2026 was Yorkville Advisors Global, an estimated $1.87M added.
  • The largest Veraxa Biotech seller in Q3 2026 was UBS Group, an estimated $153K sold.

Based on aggregated 13F filings for Q3 2026.